Recent Advances in Nanotechnology-Based Targeted Delivery Systems of Active Constituents in Natural Medicines for Cancer Treatment
Open Access
Abstract
Owing to high efficacy and safety, natural medicines have found their way into the field of cancer therapy over the past few decades. However, the effective ingredients of natural medicines have shortcomings of poor solubility and low bioavailability. Nanoparticles can not only solve the problems above but also have outstanding targeting ability. Targeting preparations can be classified into three levels, which are target tissues, cells, and organelles. On the premise of clarifying the therapeutic purpose of drugs, one or more targeting methods can be selected to achieve more accurate drug delivery and consequently to improve the anti-tumor effects of drugs and reduce toxicity and side effects. The aim of this review is to summarize the research status of natural medicines’ nano-preparations in tumor-targeting therapies to provide some references for further accurate and effective cancer treatments.Keywords
Funding Information
- Strengthening Foundation Plan for Young Teachers of School of Pharmacy, Shandong University of Traditional Chinese Medicine (KYQJ-202314)
This publication has 213 references indexed in Scilit:
- Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxelBiomaterials, 2013
- Bone matters in lung cancerAnnals of Oncology, 2012
- Cancer and Radiation Therapy: Current Advances and Future DirectionsInternational Journal of Medical Sciences, 2012
- Potency of inhibition of human DNA topoisomerase I by flavones assessed through physicochemical parametersFree Radical Biology and Medicine, 2011
- Phospholipid–Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxelDrug Development and Industrial Pharmacy, 2010
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial DrugsChemistry & Biology, 2010
- A role for neoadjuvant gemcitabine plus cisplatin in muscle‐invasive urothelial carcinoma of the bladderCancer, 2008
- Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer, 2006
- Nucleocytoplasmic Protein Transport and Recycling of Ran.Cell Structure and Function, 1999
- Protein import into the nucleusFEBS Letters, 1996